Header Logo

MARK SEUNGWOOK KIM

TitleAssistant Professor
InstitutionMD Anderson
DepartmentGynecological Oncology & Reproductive Medicine
Address1515 Holcombe Blvd.
Houston TX 77030
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Joseph R, Dasari SK, Umamaheswaran S, Mangala LS, Bayraktar E, Rodriguez-Aguayo C, Wu Y, Nguyen N, Powell RT, Sobieski M, Liu Y, Kim MS, Corvigno S, Foster K, Hanjra P, Vu TC, Chowdhury MA, Amero P, Stephan C, Lopez-Berestein G, Westin SN, Sood AK. EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer. Int J Mol Sci. 2024 Jan 20; 25(2). PMID: 38279277; PMCID: PMC10816153.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Glassman D, Kim MS, Spradlin M, Badal S, Taki M, Bhattacharya P, Dutta P, Kingsley CV, Foster KI, Animasahun O, Jeon JH, Achreja A, Jayaraman A, Kumar P, Nenwani M, Wuchu F, Bayraktar E, Wu Y, Stur E, Mangala L, Lee S, Yap TA, Westin SN, Eberlin LS, Nagrath D, Sood AK. Exploiting metabolic vulnerabilities after anti-VEGF antibody therapy in ovarian cancer. iScience. 2023 Feb 17; 26(2):106020. PMID: 36824283; PMCID: PMC9941132.
      Citations:    
    3. Noh K, Bach DH, Choi HJ, Kim MS, Wu SY, Pradeep S, Ivan C, Cho MS, Bayraktar E, Rodriguez-Aguayo C, Dasari SK, Stur E, Mangala LS, Lopez-Berestein G, Sood AK. The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene. 2021 01; 40(2):384-395. PMID: 33149280; PMCID: PMC8275353.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    4. Kim MS, Ma S, Chelariu-Raicu A, Leuschner C, Alila HW, Lee S, Coleman RL, Sood AK. Enhanced Immunotherapy with LHRH-R Targeted Lytic Peptide in Ovarian Cancer. Mol Cancer Ther. 2020 11; 19(11):2396-2406. PMID: 32943548; PMCID: PMC9399905.
      Citations: 3     Fields:    Translation:HumansAnimalsCells
    5. Ma S, Pradeep S, Villar-Prados A, Wen Y, Bayraktar E, Mangala LS, Kim MS, Wu SY, Hu W, Rodriguez-Aguayo C, Leuschner C, Liang X, Ram PT, Schlacher K, Coleman RL, Sood AK. GnRH-R-Targeted Lytic Peptide Sensitizes BRCA Wild-type Ovarian Cancer to PARP Inhibition. Mol Cancer Ther. 2019 05; 18(5):969-979. PMID: 30926640; PMCID: PMC6497555.
      Citations: 3     Fields:    Translation:HumansAnimals
    6. Lee HJ, Hanibuchi M, Kim SJ, Yu H, Kim MS, He J, Langley RR, Regenass U, Fidler IJ, Lehembre F. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. Neuro Oncol. 2016 Apr; 18(4):486-96. PMID: 26995790; PMCID: PMC4799693.
      Citations: 25     Fields:    Translation:HumansAnimalsCells
    7. Kim SJ, Lee HJ, Kim MS, Choi HJ, He J, Wu Q, Aldape K, Weinberg JS, Yung WK, Conrad CA, Langley RR, Regenass U, Fidler IJ, Lehembre F. Macitentan, a Dual Endothelin Receptor Antagonist, in Combination with Temozolomide Leads to Glioblastoma Regression and Long-term Survival in Mice. Clin Cancer Res. 2015 Oct 15; 21(20):4630-41. PMID: 26106074; PMCID: PMC4780217.
      Citations: 33     Fields:    Translation:HumansAnimalsCells
    8. Lee HJ, Yu HK, Papadopoulos JN, Kim SW, He J, Park YK, Yoon Y, Kim JS, Kim SJ. Targeted antivascular therapy with the apolipoprotein(a) kringle V, rhLK8, inhibits the growth and metastasis of human prostate cancer in an orthotopic nude mouse model. Neoplasia. 2012 Apr; 14(4):335-43. PMID: 22577348; PMCID: PMC3349259.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    9. Kim SJ, Kim JS, Kim SW, Yun SJ, He J, Brantley E, Fan D, Strickner P, Regenass U, Fidler IJ, Lehembre F. Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist. Transl Oncol. 2012 Feb; 5(1):39-47. PMID: 22348175; PMCID: PMC3281406.
      Citations: 21     
    10. Park ES, Kim SJ, Kim SW, Yoon SL, Leem SH, Kim SB, Kim SM, Park YY, Cheong JH, Woo HG, Mills GB, Fidler IJ, Lee JS. Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis. Proc Natl Acad Sci U S A. 2011 Oct 18; 108(42):17456-61. PMID: 21987811; PMCID: PMC3198333.
      Citations: 65     Fields:    Translation:HumansAnimalsCells
    11. Kim SH, Park YY, Kim SW, Lee JS, Wang D, DuBois RN. ANGPTL4 induction by prostaglandin E2 under hypoxic conditions promotes colorectal cancer progression. Cancer Res. 2011 Nov 15; 71(22):7010-20. PMID: 21937683; PMCID: PMC3217078.
      Citations: 51     Fields:    Translation:HumansAnimalsCells
    12. Yokoi K, Hawke D, Oborn CJ, Jang JY, Nishioka Y, Fan D, Kim SW, Kim SJ, Fidler IJ. Identification and validation of SRC and phospho-SRC family proteins in circulating mononuclear cells as novel biomarkers for pancreatic cancer. Transl Oncol. 2011 Apr 01; 4(2):83-91. PMID: 21461171; PMCID: PMC3069651.
      Citations: 15     
    13. Kim SJ, Kim JS, Park ES, Lee JS, Lin Q, Langley RR, Maya M, He J, Kim SW, Weihua Z, Balasubramanian K, Fan D, Mills GB, Hung MC, Fidler IJ. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia. 2011 Mar; 13(3):286-98. PMID: 21390191; PMCID: PMC3050871.
      Citations: 126     Fields:    Translation:HumansAnimalsCells
    14. Kim SJ, Kim JS, Kim SW, Brantley E, Yun SJ, He J, Maya M, Zhang F, Wu Q, Regenass U, Fidler IJ, Lehembre F. Macitentan (ACT-064992), a tissue-targeting endothelin receptor antagonist, enhances therapeutic efficacy of paclitaxel by modulating survival pathways in orthotopic models of metastatic human ovarian cancer. Neoplasia. 2011 Feb; 13(2):167-79. PMID: 21403842; PMCID: PMC3033595.
      Citations: 32     Fields:    Translation:HumansAnimalsCells
    15. Kim SW, Kim JS, Papadopoulos J, Choi HJ, He J, Maya M, Langley RR, Fan D, Fidler IJ, Kim SJ. Consistent interactions between tumor cell IL-6 and macrophage TNF-a enhance the growth of human prostate cancer cells in the bone of nude mouse. Int Immunopharmacol. 2011 Jul; 11(7):862-72. PMID: 21251905; PMCID: PMC3086935.
      Citations: 21     Fields:    Translation:HumansAnimalsCells
    16. Brantley EC, Guo L, Zhang C, Lin Q, Yokoi K, Langley RR, Kruzel E, Maya M, Kim SW, Kim SJ, Fan D, Fidler IJ. Nitric oxide-mediated tumoricidal activity of murine microglial cells. Transl Oncol. 2010 Dec 01; 3(6):380-8. PMID: 21151477; PMCID: PMC3000463.
      Citations: 28     
    17. Fidler IJ, Balasubramanian K, Lin Q, Kim SW, Kim SJ. The brain microenvironment and cancer metastasis. Mol Cells. 2010 Aug; 30(2):93-8. PMID: 20799011.
      Citations: 47     Fields:    Translation:HumansAnimalsCells
    18. Kim SH, Xia D, Kim SW, Holla V, Menter DG, Dubois RN. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010 May 15; 70(10):4054-63. PMID: 20442290; PMCID: PMC2871069.
      Citations: 35     Fields:    Translation:HumansCells
    19. Lee JW, Han HD, Shahzad MM, Kim SW, Mangala LS, Nick AM, Lu C, Langley RR, Schmandt R, Kim HS, Mao S, Gooya J, Fazenbaker C, Jackson D, Tice DA, Landen CN, Coleman RL, Sood AK. EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst. 2009 Sep 02; 101(17):1193-205. PMID: 19641174; PMCID: PMC2736292.
      Citations: 49     Fields:    Translation:HumansAnimalsCells
    20. Kim SJ, Kim JS, Papadopoulos J, Wook Kim S, Maya M, Zhang F, He J, Fan D, Langley R, Fidler IJ. Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis. Am J Pathol. 2009 May; 174(5):1972-80. PMID: 19349357; PMCID: PMC2671284.
      Citations: 61     Fields:    Translation:AnimalsCells
    21. Lin YG, Immaneni A, Merritt WM, Mangala LS, Kim SW, Shahzad MM, Tsang YT, Armaiz-Pena GN, Lu C, Kamat AA, Han LY, Spannuth WA, Nick AM, Landen CN, Wong KK, Gray MJ, Coleman RL, Bodurka DC, Brinkley WR, Sood AK. Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res. 2008 Sep 01; 14(17):5437-46. PMID: 18765535; PMCID: PMC2766914.
      Citations: 27     Fields:    Translation:HumansAnimalsCells
    22. Lu C, Shahzad MM, Wang H, Landen CN, Kim SW, Allen J, Nick AM, Jennings N, Kinch MS, Bar-Eli M, Sood AK. EphA2 overexpression promotes ovarian cancer growth. Cancer Biol Ther. 2008 Jul; 7(7):1098-103. PMID: 18443431; PMCID: PMC2705979.
      Citations: 36     Fields:    Translation:HumansAnimalsCells
    23. Hong JS, Kim SW, Koo JS. Sp1 up-regulates cAMP-response-element-binding protein expression during retinoic acid-induced mucous differentiation of normal human bronchial epithelial cells. Biochem J. 2008 Feb 15; 410(1):49-61. PMID: 17937658; PMCID: PMC3051184.
      Citations: 6     Fields:    Translation:HumansCells
    24. Aggarwal S, Kim SW, Ryu SH, Chung WC, Koo JS. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res. 2008 Feb 15; 68(4):981-8. PMID: 18281471; PMCID: PMC2921320.
      Citations: 46     Fields:    Translation:HumansCells
    25. Kim SW, Hong JS, Ryu SH, Chung WC, Yoon JH, Koo JS. Regulation of mucin gene expression by CREB via a nonclassical retinoic acid signaling pathway. Mol Cell Biol. 2007 Oct; 27(19):6933-47. PMID: 17646388; PMCID: PMC2099243.
      Citations: 35     Fields:    Translation:HumansCells
    26. Kim SW, Cheon K, Kim CH, Yoon JH, Hawke DH, Kobayashi R, Prudkin L, Wistuba II, Lotan R, Hong WK, Koo JS. Proteomics-based identification of proteins secreted in apical surface fluid of squamous metaplastic human tracheobronchial epithelial cells cultured by three-dimensional organotypic air-liquid interface method. Cancer Res. 2007 Jul 15; 67(14):6565-73. PMID: 17638865; PMCID: PMC2958044.
      Citations: 11     Fields:    Translation:HumansCells
    27. Aggarwal S, Kim SW, Cheon K, Tabassam FH, Yoon JH, Koo JS. Nonclassical action of retinoic acid on the activation of the cAMP response element-binding protein in normal human bronchial epithelial cells. Mol Biol Cell. 2006 Feb; 17(2):566-75. PMID: 16280361; PMCID: PMC1356569.
      Citations: 61     Fields:    Translation:HumansCells
    28. Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice. Clinical Cancer Research. 21:4630-4641.
    29. Consistent interactions between tumor cell IL-6 and macrophage TNF-α enhance the growth of human prostate cancer cells in the bone of nude mouse. International Immunopharmacology. 11:859-869.
    30. Treatment of experimental human breast cancer and lung cancer brain metastases in mice by macitentan, a dual antagonist of endothelin receptors, combined with paclitaxel. Neuro-Oncology. 18:486-496.
    KIM's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (202)
    Explore
    _
    Co-Authors (23)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _